Filter
3713
Filtered Results: 3713
Text search:
drug
supply
Featured
Recommendations
356
New Publications
1095
Language
Document type
No document type
2185
Studies & Reports
567
Guidelines
506
Manuals
184
Strategic & Response Plan
140
Training Material
51
Fact sheets
46
Situation Updates
18
Infographics
6
Resource Platforms
5
Brochures
3
App
1
Online Courses
1
Countries / Regions
India
249
Kenya
117
Global
117
Ethiopia
107
Uganda
103
South Africa
89
Nigeria
82
Tanzania
78
Western and Central Europe
75
Nepal
71
Malawi
69
Sierra Leone
68
Liberia
66
Myanmar / Burma
61
Zambia
60
Ghana
57
Bangladesh
54
Africa
52
Namibia
42
Rwanda
37
Ukraine
36
Eastern Europe
36
Philippines
34
Latin America and the Carribbean
34
Zimbabwe
32
Asia
30
Cambodia
28
Lesotho
26
Russia
26
South–East Asia Region
25
Botswana
22
Syria
20
Indonesia
20
Senegal
16
Mozambique
16
Congo, Democratic Republic of
15
Burkina Faso
14
East and Southern Africa
13
Middle East and North Africa
11
South Sudan
11
Eswatini/ Swaziland
11
Germany
10
Eastern Europe and Central Asia
10
Brazil
10
Georgia
10
Cameroon
9
Haiti
9
West and Central Africa
9
Thailand
8
Albania
8
Venezuela
8
Vietnam
8
Pakistan
8
Tajikistan
7
Colombia
7
Guinea
7
Sudan
7
Afghanistan
6
Western Pacific Region
6
North Macedonia
5
Benin
5
Laos
5
USA
5
Moldova
5
Sri Lanka
5
Timor Leste/ East Timor
4
China
4
Argentina
4
Lebanon
4
Yemen
4
Iraq
4
Turkey
3
Kyrgyzstan
3
Peru
3
Armenia
3
Jordan
3
Paraguay
3
North America
3
Jamaica
3
United Kingdom
3
Bhutan
3
Madagascar
3
Mexico
2
Iran
2
Canada
2
Fiji
2
Estonia
2
Morocco
2
Hungary
2
Saudi Arabia
2
France
2
Portugal
2
Papua New Guinea
2
Central African Republic
2
Poland
2
Angola
2
Libya
2
Somalia
2
North Korea
1
Switzerland
1
El Salvador
1
Serbia
1
Australia
1
Gambia
1
Kazakhstan
1
Chile
1
Singapore
1
Uzbekistan
1
Bulgaria
1
Guinea-Bissau
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Norway
1
Spain
1
Belarus
1
Bolivia
1
Greece
1
Palestine
1
Honduras
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
1607
Clinical Guidelines
324
Public Health
163
Women & Child Health
140
Key Resources
124
Pharmacy & Technologies
62
Capacity Building
50
Annual Report MEDBOX
1
Toolboxes
HIV
395
TB
330
Mental Health
232
AMR
184
COVID-19
175
Pharmacy
149
NTDs
144
Caregiver
80
NCDs
71
Malaria
71
Ebola & Marburg
56
Planetary Health
53
Conflict
52
Rapid Response
41
Global Health Education
38
Refugee
33
Health Financing Toolbox
28
Disability
23
Cholera
17
2.0 Rapid Response
17
Polio
17
Natural Hazards
16
Specific Hazards
12
Social Ethics
7
Zika
6
What at first glance appears to be simple causality – climate change leading to more and more migration – has triggered intense academic debate over the past ten years because the circumstances are complex. There is need for a thorough analysis in the ground between denying the problem and asser...
Primary health care offers a cost–effective route to achieving universal health coverage (UHC). However, primary health-care systems are weak in many low- and middle-income countries and often fail to provide comprehensive, people-centred, integrated care. We analysed the primar...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit...
Polymerase Chain Reaction (PCR) has significantly helped in early diagnosis and commencement of specific interventions for diseases control. It also plays a critical role in understanding the disease epidemiology and unraveling the transmission dynamics of the disease. This manual intends to p...
Loss and damage is an urgent concern, driven by the increasingly harmful effects of climate change. Communities are experiencing new types and forms of climate impact, of higher frequency and intensity, which they are not equipped to handle. These impacts compel vulnerable communities to migrate to ...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
Volume 1 covers emergency triage assessment and treatment, and acute care for a severely ill or acutely injured patient for approximately the first 24 hours of care. It describes the clinical procedures commonly used in emergency and acute care, and gives a summary of the medicines used and the step...
3rd edition!Large File 17 MB!
Int J Vaccines Vaccin 2016, 2(1): 00018, January 29, 2016
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated that the majority of persons with chronic hepatitis ...
March 2021
This report presents the key findings of the NFHS-5 survey in Maharashtra, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for India...
Guiding framework for development cooperation, Working paper 2017.
This document was drawn up on the basis of expert publications and inputs from partners in the
GIZ regional programme Psychosocial Support for Syrian and Iraqi Refugees and Internally
Displaced People1 in order to serve as guidanc...
Non-pharmaceutical interventions (NPI) are public health measures that aim to prevent and/or control SARS-CoV-2 transmission in the community. As long as there is no effective and safe vaccine to protect those at risk of severe COVID-19, NPI are the most effective public health interventions against...
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep...
Petersenet al.International Journal of Mental Health Systems2011,5:8http://www.ijmhs.com/content/5/1/8
